These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 37059222)

  • 41. Evaluation of a Paradigm Shift From Intravenous Antibiotics to Oral Step-Down Therapy for the Treatment of Infective Endocarditis: A Narrative Review.
    Spellberg B; Chambers HF; Musher DM; Walsh TL; Bayer AS
    JAMA Intern Med; 2020 May; 180(5):769-777. PubMed ID: 32227127
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Role of early intravenous to oral antibiotic switch therapy in the management of prosthetic hip infection treated with one- or two-stage replacement.
    Darley ES; Bannister GC; Blom AW; Macgowan AP; Jacobson SK; Alfouzan W
    J Antimicrob Chemother; 2011 Oct; 66(10):2405-8. PubMed ID: 21742678
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Switching from intravenous to oral antibiotics in hospitalized patients with community-acquired pneumonia: A real-world analysis 2010-2018.
    Kimura T; Ito M; Onozawa S
    J Infect Chemother; 2020 Jul; 26(7):706-714. PubMed ID: 32284180
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Routine antibiotic prophylaxis after normal vaginal birth for reducing maternal infectious morbidity.
    Bonet M; Ota E; Chibueze CE; Oladapo OT
    Cochrane Database Syst Rev; 2017 Nov; 11(11):CD012137. PubMed ID: 29190037
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Antimicrobial drugs for treating cholera.
    Leibovici-Weissman Y; Neuberger A; Bitterman R; Sinclair D; Salam MA; Paul M
    Cochrane Database Syst Rev; 2014 Jun; 2014(6):CD008625. PubMed ID: 24944120
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Oral anti-pseudomonal antibiotics for cystic fibrosis.
    Remmington T; Jahnke N; Harkensee C
    Cochrane Database Syst Rev; 2016 Jul; 7(7):CD005405. PubMed ID: 27412131
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Development of operationalized intravenous to oral antibiotic switch criteria.
    Akhloufi H; Hulscher M; Melles DC; Prins JM; van der Sijs H; Verbon A
    J Antimicrob Chemother; 2017 Feb; 72(2):543-546. PubMed ID: 27999021
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Early switching of antibiotic therapy from intravenous to oral using a combination of education, pocket-sized cards and switch advice: A practical intervention resulting in reduced length of hospital stay.
    Mouwen AMA; Dijkstra JA; Jong E; Buijtels PCAM; Pasker-de Jong PCM; Nagtegaal JE
    Int J Antimicrob Agents; 2020 Jan; 55(1):105769. PubMed ID: 31362046
    [TBL] [Abstract][Full Text] [Related]  

  • 49. What prevents the intravenous to oral antibiotic switch? A qualitative study of hospital doctors' accounts of what influences their clinical practice.
    Broom J; Broom A; Adams K; Plage S
    J Antimicrob Chemother; 2016 Aug; 71(8):2295-9. PubMed ID: 27121400
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Stimulation of the i.v. to oral switch of bioavailable drugs by phone calls in a Belgian tertiary care hospital.
    Vanstraelen K; Verhaegen J; Peetermans WE; Willems L; Spriet I
    Acta Clin Belg; 2013; 68(3):179-82. PubMed ID: 24156216
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Antimicrobial prophylaxis for colorectal surgery.
    Nelson RL; Gladman E; Barbateskovic M
    Cochrane Database Syst Rev; 2014 May; 2014(5):CD001181. PubMed ID: 24817514
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Pharmacokinetics and pharmacodynamics of antibacterials, antifungals, and antivirals used most frequently in neonates and infants.
    Roberts JK; Stockmann C; Constance JE; Stiers J; Spigarelli MG; Ward RM; Sherwin CM
    Clin Pharmacokinet; 2014 Jul; 53(7):581-610. PubMed ID: 24871768
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Safety of prolonged outpatient courses of intravenous antibiotics: a prospective cohort study.
    Browning S; Loewenthal MR; Freelander I; Dobson PM; Schneider K; Davis JS
    Clin Microbiol Infect; 2022 Jun; 28(6):832-837. PubMed ID: 35017063
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Intravenous-to-oral switch in antimicrobial therapy: clinical pharmacology considerations and perspectives.
    Srinivas NR
    Future Microbiol; 2017 Aug; 12():847-851. PubMed ID: 28685614
    [No Abstract]   [Full Text] [Related]  

  • 55. Oral fosfomycin versus ciprofloxacin in women with E.coli febrile urinary tract infection, a double-blind placebo-controlled randomized controlled non-inferiority trial (FORECAST).
    Ten Doesschate T; van Mens SP; van Nieuwkoop C; Geerlings SE; Hoepelman AIM; Bonten MJM
    BMC Infect Dis; 2018 Dec; 18(1):626. PubMed ID: 30518334
    [TBL] [Abstract][Full Text] [Related]  

  • 56. What do we really know about antibiotic pharmacodynamics?
    Gunderson BW; Ross GH; Ibrahim KH; Rotschafer JC
    Pharmacotherapy; 2001 Nov; 21(11 Pt 2):302S-318S. PubMed ID: 11714222
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Treatment of complicated intra-abdominal infections: comparison of the tolerability and safety of intravenous/oral trovafloxacin versus intravenous imipenem/cilastatin switching to oral amoxycillin/clavulanic acid.
    Luke DR; Peterson J
    Int J Clin Pract; 1999; 53(3):166-73. PubMed ID: 10665126
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Oral antibiotics for severe infections : an update].
    Tadini E; Masserey-Bonvin V; Emonet S; Petignat PA
    Rev Med Suisse; 2019 Sep; 15(661):1538-1542. PubMed ID: 31496186
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Pharmacokinetic and Pharmacodynamic Principles of Anti-infective Dosing.
    Onufrak NJ; Forrest A; Gonzalez D
    Clin Ther; 2016 Sep; 38(9):1930-47. PubMed ID: 27449411
    [TBL] [Abstract][Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.